🇺🇸 FDA
Pipeline program

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM) and Overweight or Obesity

BP45980

Phase 1 other active

Quick answer

A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants with Type 2 Diabetes Mellitus(T2DM) and Overweight or Obesity for Type 2 Diabetes Mellitus (T2DM) and overweight or obesity is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Type 2 Diabetes Mellitus (T2DM) and overweight or obesity
Phase
Phase 1
Modality
other
Status
active

Clinical trials